BCL2 and colorectal carcinoma: Notably, celastrol-treated human CRC cell lines (HCT-116 and SW480) exhibited diminished clonogenic capacity alongside elevated pro-apoptotic Bax and cleaved PARP levels, coupled with reduced anti-apoptotic Bcl-2 expression.